Please login to the form below

Not currently logged in
Email:
Password:

David Theil joins Noxilizer as chief financial officer

He also takes up the role of senior vice president

US-based biotech Noxilizer has appointed David Theil as its new chief financial officer and senior vice president.

Theil has over 25 years of experience in financial, administrative and operational management, specialising in start-up and middle market life sciences companies.

Before joining the biotechnology firm, Theil held various senior management positions at IGEN International, Speciality Pharmaceuticals and Supernus Pharmaceuticals.

He has also served as manager of emerging business markets group for Deloitte & Touche where he worked with clients in biotechnology, communications, healthcare and technology companies.

Lawrence Bruder, Noxilizer's president and chief executive officer, said: “David brings experience that is critical to Noxilizer at this stage of the company.

“He has worked in growing companies and understands the opportunities and challenges.”

28th January 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Research Partnership

We are the largest independent healthcare market research and consulting agencies in the world. Trusted partner to the global pharmaceutical...

Latest intelligence

Theodora Harold
A snapshot of Crescendo Biologics
PME talks to CEO Theodora Harold...
eyeforpharma Marketing and Customer Innovation Europe
By Richard Springham...
US Drug pricing
The Golden Goose
Why it’s so hard for the US to curb runaway drug prices...

Infographics